Insulin Glargine Versus Twice-Daily NPH

NCT00687453 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Insulin glargine at bedtime instead of NPH
DRUG: NPH twice-daily

Sponsor

Charles Drew University of Medicine and Science

Collaborators

[object Object]